Citations (55)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Tjerk Bueters, Sanja Juric, Anna-Karin Sohlenius-Sternbeck, Yin Hu & Johan Bylund. (2013) Rat poorly predicts the combined non-absorbed and presystemically metabolized fractions in the human. Xenobiotica 43:7, pages 607-616.
Read now
Read now
Henri Roukoz & Walid Saliba. (2007) Dofetilide: a new class III antiarrhythmic agent. Expert Review of Cardiovascular Therapy 5:1, pages 9-19.
Read now
Read now
Hanne Elming, Bente Brendorp, Ole Dyg Pedersen, Lars Køber & Christian Torp-Petersen. (2003) Dofetilide: a new drug to control cardiac arrhythmia. Expert Opinion on Pharmacotherapy 4:6, pages 973-985.
Read now
Read now
Christian Torp-Pedersen, Bente Brendorp & Lars Køber. (2000) Dofetilide: a class III anti-arrhythmic drug for the treatment of atrial fibrillation. Expert Opinion on Investigational Drugs 9:11, pages 2695-2704.
Read now
Read now
Kevin J Ward & Jaswinder S Gill. (1997) Dofetilide: first of a new generation of class III agents. Expert Opinion on Investigational Drugs 6:9, pages 1269-1281.
Read now
Read now
J. Brian Houston & David J. Carlile. (1997) Prediction of Hepatic Clearance from Microsomes, Hepatocytes, and Liver Slices. Drug Metabolism Reviews 29:4, pages 891-922.
Read now
Read now
M. J. Humphrey. (1996) Application of Metabolism and Pharmacokinetic Studies to the Drug Discovery Process. Drug Metabolism Reviews 28:3, pages 473-489.
Read now
Read now
D. K. Walker, K. C. Beaumont, D. A. Stopher & D. A. Smith. (1996) Pharmacokinetics of a series of bis(methanesulphonamido-arylalkyl)amines in the beagle dog. Xenobiotica 26:10, pages 1101-1111.
Read now
Read now
Articles from other publishers (47)
Muhammad Erfan Uddin, Eric D. Eisenmann, Yang Li, Kevin M. Huang, Dominique A. Garrison, Zahra Talebi, Alice A. Gibson, Yan Jin, Mahesh Nepal, Ingrid M. Bonilla, Qiang Fu, Xinxin Sun, Alec Millar, Mikhail Tarasov, Christopher E. Jay, Xiaoming Cui, Heidi J. Einolf, Ryan M. Pelis, Sakima A. Smith, Przemysław B. Radwański, Douglas H. Sweet, Jörg König, Martin F. Fromm, Cynthia A. Carnes, Shuiying Hu & Alex Sparreboom. (2022) MATE1 Deficiency Exacerbates Dofetilide-Induced Proarrhythmia. International Journal of Molecular Sciences 23:15, pages 8607.
Crossref
Crossref
Mikael Wallman, Jens Markus Borghardt, Eric Martel, Nicolas Pairet, Michael Markert & Mats Jirstrand. (2022) An integrative pharmacokinetic-cardiovascular physiology modelling approach based on in vivo dog studies including five reference compounds. Journal of Pharmacological and Toxicological Methods 115, pages 107171.
Crossref
Crossref
Yan Zhang & Donald Miller. 2021. Transporters and Drug‐Metabolizing Enzymes in Drug Toxicity. Transporters and Drug‐Metabolizing Enzymes in Drug Toxicity
339
376
.
Mikael Wallman, Stefan Scheuerer, Eric Martel, Nicolas Pairet, Mats Jirstrand & Johan Gabrielsson. (2021) An Integrative Approach for Improved Assessment of Cardiovascular Safety Data. Journal of Pharmacology and Experimental Therapeutics 377:2, pages 218-231.
Crossref
Crossref
Muhammad Erfan Uddin, Xinxin Sun, Kevin M. Huang, Shuiying Hu, Cynthia A. Carnes, Alex Sparreboom & Qiang Fu. (2019) Development and validation of a UPLC-MS/MS analytical method for dofetilide in mouse plasma and urine, and its application to pharmacokinetic study. Journal of Pharmaceutical and Biomedical Analysis 172, pages 183-188.
Crossref
Crossref
Louise Prestipino, Jaimie W. Polson, Elisabeth Brolin & Helen E. Ritchie. (2018)
Long-term programming effects on blood pressure following gestational exposure to the
I
Kr
blocker Dofetilide
. Physiological Reports 6:5, pages e13621.
Crossref
Crossref
Verena Gotta, Zhiyi Yu, Frank Cools, Karel Ammel, David J. Gallacher, Sandra A. G. Visser, Frederick Sannajust, Pierre Morissette, Meindert Danhof & Piet H. Graaf. (2016)
Application of a systems pharmacology model for translational prediction of
hERG
‐mediated
QT
c prolongation
. Pharmacology Research & Perspectives 4:6.
Crossref
Crossref
Eve-Irene Lepist & Adrian S. Ray. (2016) Renal Transporter-Mediated Drug-Drug Interactions: Are They Clinically Relevant?. The Journal of Clinical Pharmacology 56, pages S73-S81.
Crossref
Crossref
Helen Ritchie, Diana Oakes, Tzong-tyng Hung, Elizabeth Hegedus, Shreya Sood & William Webster. (2015) The Effect of Dofetilide on the Heart Rate of GD11 and GD13 Rat Embryos, in vivo, Using Ultrasound. Birth Defects Research Part B: Developmental and Reproductive Toxicology 104:5, pages 196-203.
Crossref
Crossref
Joanna Parkinson, Sandra A.G. Visser, Philip Jarvis, Chris Pollard, Jean-Pierre Valentin, James W.T. Yates & Lorna Ewart. (2013) Translational pharmacokinetic–pharmacodynamic modeling of QTc effects in dog and human. Journal of Pharmacological and Toxicological Methods 68:3, pages 357-366.
Crossref
Crossref
Helen E. Ritchie, Deena H. Ababneh, Diana J. Oakes, Carl A. Power & William S. Webster. (2013) The Teratogenic Effect of Dofetilide during Rat Limb Development and Association with Drug-Induced Bradycardia and Hypoxia in the Embryo. Birth Defects Research Part B: Developmental and Reproductive Toxicology 98:2, pages 144-153.
Crossref
Crossref
Herbert M Himmel, Alexandra Bussek, Michael Hoffmann, Rolf Beckmann, Horst Lohmann, Matthias Schmidt & Erich Wettwer. (2012) Field and action potential recordings in heart slices: correlation with established in vitro and in vivo models. British Journal of Pharmacology 166:1, pages 276-296.
Crossref
Crossref
. 2012. Pharmacokinetics and Metabolism in Drug Design. Pharmacokinetics and Metabolism in Drug Design
19
40
.
Iftekhar Mahmood. (2009) Role of Fixed Coefficients and Exponents in the Prediction of Human Drug Clearance: How Accurate are the Predictions from One or Two Species?. Journal of Pharmaceutical Sciences 98:7, pages 2472-2493.
Crossref
Crossref
Karin Tunblad, Lars Lindbom, Lynn McFadyen, E. Niclas Jonsson, Scott Marshall & Mats O. Karlsson. (2008) The use of clinical irrelevance criteria in covariate model building with application to dofetilide pharmacokinetic data. Journal of Pharmacokinetics and Pharmacodynamics 35:5, pages 503-526.
Crossref
Crossref
T M Haushalter, G S Friedrichs, D L Reynolds, M Barecki-Roach, G Pastino, R Hayes & A S Bass. (2008) The cardiovascular and pharmacokinetic profile of dofetilide in conscious telemetered beagle dogs and cynomolgus monkeys. British Journal of Pharmacology 154:7, pages 1457-1464.
Crossref
Crossref
Anna Ollerstam, Sandra A.G. Visser, Göran Duker, Tomas Forsberg, Anna H. Persson, Lars B. Nilsson, Jan-Arne Björkman, Johan Gabrielsson & Ahmad Al-Saffar. (2007) Comparison of the QT interval response during sinus and paced rhythm in conscious and anesthetized beagle dogs. Journal of Pharmacological and Toxicological Methods 56:2, pages 131-144.
Crossref
Crossref
Niklaus Dürmüller, Philippe Guillaume, Pierre Lacroix, Roger D. Porsolt & Paul Moser. (2007) The use of the dog electroencephalogram (EEG) in safety pharmacology to evaluate proconvulsant risk. Journal of Pharmacological and Toxicological Methods 56:2, pages 234-238.
Crossref
Crossref
Kristen Bova Campbell, Jennifer D. Mando, Alice L. Gray & Eric Robinson. (2012) Management of Dofetilide Overdose in a Patient with Known Cocaine Abuse. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 27:3, pages 459-463.
Crossref
Crossref
Anusak Kijtawornrat, Yoshinori Nishijima, Brian M. Roche, Bruce W. Keene & Robert L. Hamlin. (2006) Use of a Failing Rabbit Heart as a Model to Predict Torsadogenicity. Toxicological Sciences 93:1, pages 205-212.
Crossref
Crossref
Huadong Tang & Michael Mayersohn. (2006) A global examination of allometric scaling for predicting human drug clearance and the prediction of large vertical allometry**This work was presented at the American Association of Pharmaceutical Scientists Annual meeting, Salt Lake City, USA, Oct. 26, 2003.. Journal of Pharmaceutical Sciences 95:8, pages 1783-1799.
Crossref
Crossref
Anna Ollerstam, Sandra A.G. Visser, Anna H. Persson, Göran Eklund, Lars B. Nilsson, Tomas Forsberg, Stig Johan Wiklund, Johan Gabrielsson, Göran Duker & Ahmad Al-Saffar. (2006) Pharmacokinetic-pharmacodynamic modeling of drug-induced effect on the QT interval in conscious telemetered dogs. Journal of Pharmacological and Toxicological Methods 53:2, pages 174-183.
Crossref
Crossref
F. A. Brightman, D. E. Leahy, G. E. Searle & S. Thomas. (2006) APPLICATION OF A GENERIC PHYSIOLOGICALLY BASED PHARMACOKINETIC MODEL TO THE ESTIMATION OF XENOBIOTIC LEVELS IN HUMAN PLASMA. Drug Metabolism and Disposition 34:1, pages 94-101.
Crossref
Crossref
Huadong Tang & Michael Mayersohn. (2005) A NOVEL MODEL FOR PREDICTION OF HUMAN DRUG CLEARANCE BY ALLOMETRIC SCALING. Drug Metabolism and Disposition 33:9, pages 1297-1303.
Crossref
Crossref
Shekhar Srivastava, Leon Collis, Anita Go, Salvatore Mancarella, William A Coetzee & Michael Artman. (2005) Paradoxical Effect of Dofetilide on Action Potential Duration and Calcium Transient Amplitude in Newborn Rabbit Ventricular Myocytes. Journal of Cardiovascular Pharmacology 45:2, pages 165-174.
Crossref
Crossref
Toshihiro Wajima, Kazuya Fukumura, Yoshitaka Yano & Takayoshi Oguma. (2003) Prediction of Human Pharmacokinetics from Animal Data and Molecular Structural Parameters using Multivariate Regression Analysis: Oral Clearance. Journal of Pharmaceutical Sciences 92:12, pages 2427-2440.
Crossref
Crossref
Yuan H Zhao, Michael H Abraham, Joelle Le, Anne Hersey, Chris N Luscombe, Gordon Beck, Brad Sherborne & Ian Cooper. (2003) Evaluation of rat intestinal absorption data and correlation with human intestinal absorption. European Journal of Medicinal Chemistry 38:3, pages 233-243.
Crossref
Crossref
Howard N.E Stevens, Clive G Wilson, Peter G Welling, Massoud Bakhshaee, Julie S Binns, Alan C Perkins, Malcolm Frier, Elaine P Blackshaw, Margaret W Frame, Don J Nichols, Michael J Humphrey & Steve R Wicks. (2002) Evaluation of Pulsincap™ to provide regional delivery of dofetilide to the human GI tract. International Journal of Pharmaceutics 236:1-2, pages 27-34.
Crossref
Crossref
I. Mahmood. (2002) Prediction of Clearance in Humans from In Vitro Human Liver Microsomes and Allometric Scaling. A Comparative Study of the Two Approaches. Drug Metabolism and Drug Interactions 19:1.
Crossref
Crossref
Brian F. Johnson, Shu‐Lin Cheng & Jurgen Venitz. (2013) Transient Kinetic and Dynamic Interactions between Verapamil and Dofetilide, a Class III Antiarrhythmic. The Journal of Clinical Pharmacology 41:11, pages 1248-1256.
Crossref
Crossref
Paul Morgan. (2001) The use of preclinical pharmacokinetic and pharmacodynamic data to predict clinical doses: current and future perspectives. International Congress Series 1220, pages 1-12.
Crossref
Crossref
Iftekhar Mahmood. (2013) Interspecies Scaling: Role of Protein Binding in the Prediction of Clearance from Animals to Humans. The Journal of Clinical Pharmacology 40:12, pages 1439-1446.
Crossref
Crossref
J. Paul MounseyJohn P. DiMarco. (2000) Dofetilide. Circulation 102:21, pages 2665-2670.
Crossref
Crossref
Rodney H. Falk & Jeanne M. DeCara. (2000) Dofetilide: A new pure class III antiarrhythmic agent. American Heart Journal 140:5, pages 697-706.
Crossref
Crossref
Iftekhar Mahmood. (2000) Critique of Prospective Allometric Scaling: Does the Emperor Have Clothes?. The Journal of Clinical Pharmacology 40:6, pages 671-674.
Crossref
Crossref
Dennis J. CadaDanial E. BakerTerri Levien. (2017) Dofetilide. Hospital Pharmacy 35:5, pages 526-535.
Crossref
Crossref
Iftekhar Mahmood. (2013) Prospective Allometric Scaling: Does the Emperor Have Clothes?. The Journal of Clinical Pharmacology 40:4, pages 341-344.
Crossref
Crossref
I. Mahmood. (2000) Can Absolute Oral Bioavailability in Humans be Predicted from Animals? A Comparison of Allometry and Different Indirect Methods. Drug Metabolism and Drug Interactions 16:2.
Crossref
Crossref
James S Kalus & Vincent F Mauro. (2016) Dofetilide: A Class III-Specific Antiarrhythmic Agent. Annals of Pharmacotherapy 34:1, pages 44-56.
Crossref
Crossref
Samantha Abel, Donald J. Nichols, Christopher J. Brearley & Malcolm D. Eve. (2003) Effect of cimetidine and ranitidine on pharmacokinetics and pharmacodynamics of a single dose of dofetilide. British Journal of Clinical Pharmacology 49:1, pages 64-71.
Crossref
Crossref
Ruey J. Sung & Michael R. LauerRuey J. Sung & Michael R. Lauer. 2000. Fundamental Approaches to the Management of Cardiac Arrhythmias. Fundamental Approaches to the Management of Cardiac Arrhythmias
91
130
.
Lars Frost, Poul Erik Mortensen, Jens Tingleff, Eivind Stoud Platou, Evald Høj Christiansen & Niels Christiansen. (1997) Efficacy and safety of dofetilide, a new class III antiarrhythmic agent, in acute termination of atrial fibrillation or flutter after coronary artery bypass surgery. International Journal of Cardiology 58:2, pages 135-140.
Crossref
Crossref
S.F. Campbell. 1997. Proceedings XIVth International Symposium on Medicinal Chemistry. Proceedings XIVth International Symposium on Medicinal Chemistry
61
70
.
Takafumi Iwatsubo, Noriko Hirota, Tsuyoshi Ooie, Hiroshi Suzuki, Noriaki Shimada, Kan Chiba, Takashi Ishizaki, Carol E. Green, Charles A. Tyson & Yuichi Sugiyama. (1997) Prediction of in vivo drug metabolism in the human liver from in vitro metabolism data. Pharmacology & Therapeutics 73:2, pages 147-171.
Crossref
Crossref
W. S. Webster, P. D. C. Brown-Woodman, M. D. Snow & B. R. G. Danielsson. (1996) Teratogenic potential of almokalant, dofetilide, andd-sotalol: Drugs with potassium channel blocking activity. Teratology 53:3, pages 168-175.
Crossref
Crossref
DEBRA S. ECHT, JOHN T. LEE, KATHERINE T. MURRAY, VICKEN VORPERIAN, S. MARCUS BORGANEELI, DIANE M. CRAWFORD, TIEMAN FRIEDRICH & DAN M. RODEN. (2007) A Randomized, Double‐Blind, Placebo‐Controlled, Dose‐Ranging Study of Dofetilide in Patients with Inducible Sustained Ventricular Tachyarrhythmias. Journal of Cardiovascular Electrophysiology 6:9, pages 687-699.
Crossref
Crossref
Franck Le Coz, Christian Funck-Brentano, Thierry Morell, Mathieu M. Ghadanfar & Patrice Jaillon. (1995) Pharmacokinetic and pharmacodynamic modeling of the effects of oral and intravenous administrations of dofetilide on ventricular repolarization*. Clinical Pharmacology & Therapeutics 57:5, pages 533-542.
Crossref
Crossref